208 related articles for article (PubMed ID: 37854130)
1. Jiawei Danxuan Koukang Alleviates Arecoline Induced Oral Mucosal Lesions: Network Pharmacology and the Combined Ultra-High Performance Liquid Chromatography (UPLC) and Mass Spectrometry (MS).
Zhou L; Tan J; Dai Y; Zhu K; Xiao Y; Wu D; Wang Z; Tan Y; Qin Y
Drug Des Devel Ther; 2023; 17():3085-3101. PubMed ID: 37854130
[TBL] [Abstract][Full Text] [Related]
2. Augmented mRNA expression of tissue inhibitor of metalloproteinase-1 in buccal mucosal fibroblasts by arecoline and safrole as a possible pathogenesis for oral submucous fibrosis.
Shieh DH; Chiang LC; Shieh TY
Oral Oncol; 2003 Oct; 39(7):728-35. PubMed ID: 12907213
[TBL] [Abstract][Full Text] [Related]
3. Tanshinone Suppresses Arecoline-Induced Epithelial-Mesenchymal Transition in Oral Submucous Fibrosis by Epigenetically Reactivating the p53 Pathway.
Zheng L; Guan ZJ; Pan WT; Du TF; Zhai YJ; Guo J
Oncol Res; 2018 Apr; 26(3):483-494. PubMed ID: 28550687
[TBL] [Abstract][Full Text] [Related]
4. Effects of arecoline, safrole, and nicotine on collagen phagocytosis by human buccal mucosal fibroblasts as a possible mechanism for oral submucous fibrosis in Taiwan.
Shieh DH; Chiang LC; Lee CH; Yang YH; Shieh TY
J Oral Pathol Med; 2004 Oct; 33(9):581-7. PubMed ID: 15357680
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of miR-497 Attenuates Oral Submucous Fibrosis by Inhibiting Myofibroblast Transdifferentiation in Buccal Mucosal Fibroblasts.
Huang J; Zhang H; Fan X; Guo J
Oral Health Prev Dent; 2022 Jun; 20(1):339-348. PubMed ID: 35920886
[TBL] [Abstract][Full Text] [Related]
6. Arecoline-induced myofibroblast transdifferentiation from human buccal mucosal fibroblasts is mediated by ZEB1.
Chang YC; Tsai CH; Lai YL; Yu CC; Chi WY; Li JJ; Chang WW
J Cell Mol Med; 2014 Apr; 18(4):698-708. PubMed ID: 24400868
[TBL] [Abstract][Full Text] [Related]
7. Elevation of S100A4 expression in buccal mucosal fibroblasts by arecoline: involvement in the pathogenesis of oral submucous fibrosis.
Yu CC; Tsai CH; Hsu HI; Chang YC
PLoS One; 2013; 8(1):e55122. PubMed ID: 23383075
[TBL] [Abstract][Full Text] [Related]
8. miR-200c inhibits the arecoline-associated myofibroblastic transdifferentiation in buccal mucosal fibroblasts.
Lu MY; Yu CC; Chen PY; Hsieh PL; Peng CY; Liao YW; Yu CH; Lin KH
J Formos Med Assoc; 2018 Sep; 117(9):791-797. PubMed ID: 29958727
[TBL] [Abstract][Full Text] [Related]
9. miR-200b ameliorates myofibroblast transdifferentiation in precancerous oral submucous fibrosis through targeting ZEB2.
Liao YW; Yu CC; Hsieh PL; Chang YC
J Cell Mol Med; 2018 Sep; 22(9):4130-4138. PubMed ID: 29893466
[TBL] [Abstract][Full Text] [Related]
10. Curcumin relieves arecoline-induced oral submucous fibrosis via inhibiting the LTBP2/NF-κB axis.
Zhang L; Tan J; Liu Y; Luo M
Oral Dis; 2024 May; 30(4):2314-2324. PubMed ID: 37382472
[TBL] [Abstract][Full Text] [Related]
11. Elevation of Twist expression by arecoline contributes to the pathogenesis of oral submucous fibrosis.
Lee YH; Yang LC; Hu FW; Peng CY; Yu CH; Yu CC
J Formos Med Assoc; 2016 May; 115(5):311-7. PubMed ID: 26088962
[TBL] [Abstract][Full Text] [Related]
12. E3 ligase carboxyl-terminus of Hsp70-interacting protein (CHIP) suppresses fibrotic properties in oral mucosa.
Chen SC; Liu CM; Hsieh PL; Liao YW; Lin YJ; Yu CC; Yu CH
J Formos Med Assoc; 2020 Feb; 119(2):595-600. PubMed ID: 31653576
[TBL] [Abstract][Full Text] [Related]
13. Raised keratinocyte growth factor-1 expression in oral submucous fibrosis in vivo and upregulated by arecoline in human buccal mucosal fibroblasts in vitro.
Tsai CH; Yang SF; Chen YJ; Chou MY; Chang YC
J Oral Pathol Med; 2005 Feb; 34(2):100-5. PubMed ID: 15641989
[TBL] [Abstract][Full Text] [Related]
14. Role of the arecoline/YAP1/BMP4 pathway in promoting endothelial-mesenchymal transition in oral submucous fibrosis.
Yao M; Li J; Yuan S; Zhu X; Hu Z; Li Q; Cao R; Wang W; Fang C
J Oral Pathol Med; 2020 Apr; 49(4):305-310. PubMed ID: 31397922
[TBL] [Abstract][Full Text] [Related]
15. PDE12 disrupts mitochondrial oxidative phosphorylation and mediates mitochondrial dysfunction to induce oral mucosal epithelial barrier damage in oral submucous fibrosis.
Wei Q; Chen L; Luo W; Chen C; Shi Y; Xie J; Xie X; Luo HB
Eur J Pharmacol; 2024 Mar; 967():176353. PubMed ID: 38325798
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-13 contributes to the occurrence of oral submucosal fibrosis.
Wang L; Tang Z; Huang J
J Cell Mol Med; 2023 Jul; 27(13):1797-1805. PubMed ID: 37337411
[TBL] [Abstract][Full Text] [Related]
17. Deficiency in collagen and fibronectin phagocytosis by human buccal mucosa fibroblasts in vitro as a possible mechanism for oral submucous fibrosis.
Tsai CC; Ma RH; Shieh TY
J Oral Pathol Med; 1999 Feb; 28(2):59-63. PubMed ID: 9950251
[TBL] [Abstract][Full Text] [Related]
18. Hypoxic regulation of plasminogen activator inhibitor-1 expression in human buccal mucosa fibroblasts stimulated with arecoline.
Tsai CH; Lee SS; Chang YC
J Oral Pathol Med; 2015 Oct; 44(9):669-73. PubMed ID: 25367145
[TBL] [Abstract][Full Text] [Related]
19. miR-203 inhibits arecoline-induced epithelial-mesenchymal transition by regulating secreted frizzled-related protein 4 and transmembrane-4 L six family member 1 in oral submucous fibrosis.
Zheng L; Jian X; Guo F; Li N; Jiang C; Yin P; Min AJ; Huang L
Oncol Rep; 2015 Jun; 33(6):2753-60. PubMed ID: 25872484
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of HIF1A-AS1 impedes the arecoline-induced migration activity of human oral mucosal fibroblasts.
Wang YK; Liu CM; Lin T; Fang CY; Yu CC; Yu CH
J Formos Med Assoc; 2020 Apr; 119(4):879-883. PubMed ID: 31959495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
